Key result
Finerenone shows cardiorenal protection across diabetes, CKD, and heart failure with LVEF >=40%.
Why the study?
The progression of the cardiorenal continuum comprising type 2 diabetes, chronic kidney disease, and chronic heart failure is driven by chronic inflammation and fibrosis, requiring modern strategies for cardiorenal protection.
Case Report (n=1)
This case report and review illustrates practical clinical algorithms for initiating, titrating, and monitoring finerenone for cardiorenal protection in patients with CKD and HF with LVEF >=40%.
Answers are grounded in this paper and cite their sources.
Case-derived algorithms for finerenone titration in cardiorenal patients require prospective validation; leaves open broader adoption pending RCTs.
The combination of type 2 diabetes, chronic kidney disease, and chronic heart failure (CHF) forms a cardiorenal continuum, the progression of which is driven by chronic inflammation and fibrosis. This article discusses the role of finerenone, a nonsteroidal selective mineralocorticoid receptor antagonist, in modern strategies for cardiorenal protection, based on data from the FIDELIO-DKD, FIGARO-DKD, FIDELITY, and FINEARTS-HF studies. Particular attention is paid to the drug’s new indication for the treatment of CHF with a left ventricular ejection fraction ≥40%, including in patients without diabetes mellitus. Using a clinical case study, the article demonstrates the selection algorithm, rules for initiation and titration, laboratory monitoring, and principles of multidisciplinary care.
No takes yet. Share an insight, caveat, or question.
Khalimov et al. (2026) conducted a case report in Chronic heart failure with left ventricular ejection fraction >=40%, chronic kidney disease, and type 2 diabetes (n=1). Finerenone was evaluated on Cardiorenal protection and treatment of chronic heart failure with LVEF >=40%. Finerenone provides cardiorenal protection across the continuum of type 2 diabetes, chronic kidney disease, and chronic heart failure with LVEF >=40%.
Synapse has enriched 10 related papers. Consider them for comparative context: